| 1 |
19067473 | Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies. | 2009 |
1 |
| 2 |
19515014 | Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. | 2009 |
1 |
| 3 |
20167000 | New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II. | 2009 Dec |
1 |
| 4 |
15537834 | Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner. | 2005 Feb |
3 |